Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Annovis Bio, Inc. (ANVS) had Pre-Tax Income of $-14.82M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-14.82M |
|
-- |
|
-- |
|
$14.38M |
|
$-14.38M |
|
$-0.44M |
|
|
Pre-Tax Income |
$-14.82M |
$-14.82M |
|
$-14.82M |
|
$-14.82M |
|
$-14.82M |
|
$-14.82M |
|
$-14.38M |
|
$-14.38M |
|
37.52M |
|
37.52M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$22.04M |
|
-- |
|
-- |
|
$22.04M |
|
$6.36M |
|
-- |
|
$19.93M |
|
$26.29M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
42.61M |
|
| Cash Flow Statement Financials | |
$-30.93M |
|
-- |
|
$30.12M |
|
$19.53M |
|
$18.73M |
|
$-0.80M |
|
$1.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
348.35% |
|
348.35% |
|
-67.25% |
|
348.35% |
|
$-0.10 |
|
$-0.82 |
|
$-0.82 |
|